DR. MICHAEL EDWARD PERRAUT M.D. NPI 1013042209

NPI Details

DR. Michael Edward Perraut, M.D. is an internal medicine in California, MD with 21 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Michael Edward Perraut, M.D. NPI is 1013042209. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
Graduation Year:2004

The provider's business location address is:

22590 SHADY CT
CALIFORNIA, MD
ZIP 20619-009
Phone: (301) 737-0500
Fax: (301) 737-3351

The NPI 1013042209 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique (HCPCS:87634)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Urinalysis, manual test (HCPCS:81002)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Emergency department visit for life threatening or functioning severity (HCPCS:99285)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Administration of vaccine, each additional vaccine (HCPCS:90472)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of vaccine (HCPCS:90471)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
• Removal of impacted ear wax (HCPCS:69210)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Emergency department visit for problem of high severity (HCPCS:99284)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Administration and interpretation of patient-focused health risk assessment (HCPCS:96160)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Critical care, first 30-74 minutes (HCPCS:99291)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use (HCPCS:91301)
• Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less (HCPCS:12001)
• Blood glucose (sugar) test performed by hand-held instrument (HCPCS:82962)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)

The enumeration date for this NPI number is 2/21/2007 and was last updated on 4/20/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: